NO993738L - 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi - Google Patents
2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemiInfo
- Publication number
- NO993738L NO993738L NO993738A NO993738A NO993738L NO 993738 L NO993738 L NO 993738L NO 993738 A NO993738 A NO 993738A NO 993738 A NO993738 A NO 993738A NO 993738 L NO993738 L NO 993738L
- Authority
- NO
- Norway
- Prior art keywords
- amino
- substituted pyridines
- arteriosclerosis
- treatment
- lipoproteinemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19704243A DE19704243A1 (de) | 1997-02-05 | 1997-02-05 | Neue 2-Amino-substituierte Pyridine |
| PCT/EP1998/000362 WO1998034920A1 (de) | 1997-02-05 | 1998-01-23 | 2-amino-substituierte pyridine verwendbar zur behandlung von arteriosklerose und hyperlipoproteinemie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993738D0 NO993738D0 (no) | 1999-08-02 |
| NO993738L true NO993738L (no) | 1999-09-17 |
Family
ID=7819326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993738A NO993738L (no) | 1997-02-05 | 1999-08-02 | 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973744A1 (cs) |
| JP (1) | JP2001510478A (cs) |
| KR (1) | KR20000070756A (cs) |
| CN (1) | CN1252057A (cs) |
| AU (1) | AU730109B2 (cs) |
| BG (1) | BG103631A (cs) |
| BR (1) | BR9807181A (cs) |
| CA (1) | CA2279636A1 (cs) |
| CZ (1) | CZ279299A3 (cs) |
| DE (1) | DE19704243A1 (cs) |
| HU (1) | HUP0001022A2 (cs) |
| ID (1) | ID24208A (cs) |
| IL (1) | IL131127A0 (cs) |
| NO (1) | NO993738L (cs) |
| NZ (1) | NZ337011A (cs) |
| PL (1) | PL334899A1 (cs) |
| SK (1) | SK104099A3 (cs) |
| TR (1) | TR199901857T2 (cs) |
| WO (1) | WO1998034920A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0210519A (pt) | 2001-06-22 | 2004-06-22 | Pfizer Prod Inc | Composições farmacêuticas de adsorvatos de fármaco amorfo |
| DE60233874D1 (de) | 2001-06-22 | 2009-11-12 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
| BR0307344A (pt) | 2002-02-01 | 2004-12-14 | Pfizer Prod Inc | Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica |
| AU2004222436A1 (en) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate |
| WO2005011635A2 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| WO2005030185A2 (en) | 2003-09-26 | 2005-04-07 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
| DOP2005000123A (es) * | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
| WO2006032987A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Indoline compounds and their use in the treatment of arteriosclerosis |
| EP2548894A1 (en) | 2005-02-03 | 2013-01-23 | Bend Research, Inc. | Pharmaceutical compositions with enhanced performance |
| US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
-
1997
- 1997-02-05 DE DE19704243A patent/DE19704243A1/de not_active Withdrawn
-
1998
- 1998-01-23 TR TR1999/01857T patent/TR199901857T2/xx unknown
- 1998-01-23 KR KR1019997007015A patent/KR20000070756A/ko not_active Application Discontinuation
- 1998-01-23 NZ NZ337011A patent/NZ337011A/en unknown
- 1998-01-23 CA CA002279636A patent/CA2279636A1/en not_active Abandoned
- 1998-01-23 AU AU62123/98A patent/AU730109B2/en not_active Ceased
- 1998-01-23 EP EP98904126A patent/EP0973744A1/de not_active Ceased
- 1998-01-23 SK SK1040-99A patent/SK104099A3/sk unknown
- 1998-01-23 CN CN98803916A patent/CN1252057A/zh active Pending
- 1998-01-23 JP JP53369198A patent/JP2001510478A/ja active Pending
- 1998-01-23 CZ CZ992792A patent/CZ279299A3/cs unknown
- 1998-01-23 IL IL13112798A patent/IL131127A0/xx unknown
- 1998-01-23 HU HU0001022A patent/HUP0001022A2/hu unknown
- 1998-01-23 ID IDW990821D patent/ID24208A/id unknown
- 1998-01-23 PL PL98334899A patent/PL334899A1/xx unknown
- 1998-01-23 WO PCT/EP1998/000362 patent/WO1998034920A1/de not_active Application Discontinuation
- 1998-01-23 BR BR9807181-5A patent/BR9807181A/pt not_active IP Right Cessation
-
1999
- 1999-08-02 NO NO993738A patent/NO993738L/no not_active Application Discontinuation
- 1999-08-03 BG BG103631A patent/BG103631A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1252057A (zh) | 2000-05-03 |
| JP2001510478A (ja) | 2001-07-31 |
| BR9807181A (pt) | 2000-01-25 |
| IL131127A0 (en) | 2001-01-28 |
| DE19704243A1 (de) | 1998-08-06 |
| CZ279299A3 (cs) | 1999-11-17 |
| NO993738D0 (no) | 1999-08-02 |
| PL334899A1 (en) | 2000-03-27 |
| BG103631A (en) | 2000-11-30 |
| AU730109B2 (en) | 2001-02-22 |
| SK104099A3 (en) | 2000-01-18 |
| HUP0001022A2 (hu) | 2000-09-28 |
| KR20000070756A (ko) | 2000-11-25 |
| NZ337011A (en) | 2001-04-27 |
| WO1998034920A1 (de) | 1998-08-13 |
| AU6212398A (en) | 1998-08-26 |
| TR199901857T2 (xx) | 1999-10-21 |
| ID24208A (id) | 2000-07-13 |
| CA2279636A1 (en) | 1998-08-13 |
| EP0973744A1 (de) | 2000-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993738L (no) | 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi | |
| GEP20032922B (en) | Benzoheterocycles and Their Use as MEK Inhibitors | |
| NO20062130L (no) | 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft | |
| NO20074773L (no) | Caspaseinhibitorer og anvendelse derav | |
| DE69919334D1 (de) | Phenylalaninderivate als inhibitoren von alpha4 integrinen | |
| MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
| ATE301460T1 (de) | Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält. | |
| ATE260910T1 (de) | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) | |
| GEP20084539B (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain | |
| NO20013680L (no) | Ketolidantibiotika | |
| WO1998042659A3 (en) | Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals | |
| NO984740L (no) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler | |
| NO20044767L (no) | Farmasoytisk formulering med modifisert frigjoring | |
| GEP20002187B (en) | Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation | |
| EP1695711A3 (en) | Parenteral formulations comprising boronic acid species for selective thrombin inhibition | |
| NO20055750L (no) | Nye kjemiske forbindelser | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| ATE233252T1 (de) | Substituierte dihydrobenzofurane als pde- hemmstoffe | |
| NO20002371L (no) | 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom | |
| DE69927584D1 (de) | Pharmazeutische zubereitungen zur behandlung von magengeschwüren | |
| DE69736945D1 (de) | Biphenylverbindungen sowie ihre anwendung als östrogene mittel | |
| EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
| DE59201013D1 (de) | Substituierte Mandelsäurederivate, als 5-Lipoxygenasehemmer. | |
| EP1123692A3 (fr) | Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |